DSM Biomedical Introduces Sustainability Initiative for Dyneema Purity® UHMWPE Medical-Grade Fiber at AAOS 2023
DSM Biomedical, the world's unrivaled biomaterials expert and committed partner in driving sustainable innovation in healthcare, is proud to announce its newest sustainability initiative – Bio-based Dyneema Purity® fiber - that leverages its existing UHMWPE Medical-Grade Fiber portfolio and is now certified by a globally renowned certification body, International Sustainability and Carbon Certification (ISCC), to ensure full compliance and traceability.
LAS VEGAS, March 8, 2023 /PRNewswire-PRWeb/ -- As a leader in sustainability, DSM Biomedical is proud to be a pioneer in sustainable solutions that enable circularity and reduce Scope 3 Emissions in the Medical Device Chain. As a key strategic priority, the company is now offering a Bio-Based Certificate for its existing trusted Dyneema Purity® UHMWPE fiber portfolio by applying a mass balancing approach.¹ As of 2024, this Bio-Based Certificate will be available for the full Dyneema Purity® fiber portfolio, with no disruption to the supply chain. This is achieved through DSM Biomedical's initiative to identify process technologies of upstream suppliers that ensure product equivalency, responsible choice of feedstock from sustainable forestry and no disruption to the food chain. Our suppliers additionally ensure a fully traceable supply chain from forest to final product.
The Dyneema Purity® Bio-Based material will be carrying the globally recognized ISCC Plus Certification and will not require re-qualification of downstream products. In doing so, DSM Biomedical is actively engaging with its partners, ultimately giving them an opportunity to divest from fossil fuels and move towards a circular, Bio-Based economy, while maintaining the identical quality and performance characteristics of their Dyneema Purity® UHMWPE fiber offerings.
Michelle Ortiz, VP of Innovation and Sustainability at DSM Biomedical, commented, "Sustainability is part of our DNA at DSM Biomedical, and circular thinking is woven into our innovation programs. Through our pipeline of science-based concepts, we are helping our partners achieve their ESG goals across the various life cycles of their products. For this initiative, we are eliminating a key fossil resource from our supply chain and leveraging the latest technology in biorefining developed by our channel partners, to ensure that our Dyneema Purity® UHMWPE fibers are more sustainable as a result. In doing so, we also ensure a smooth, fast, and effortless transition by guaranteeing zero change implications for our valued partners in the Medical Device industry."
Eric Shelton, DSM Biomedical's VP of Global Commercial added: "We are excited to collaborate with our partners on this initiative, and to start the dialogue at AAOS this year, as we explore new ways of tackling the industry's ESG challenges together. In every partner discussion that we've had on this topic, it becomes clearer to me that we all have our own unique priorities when it comes to hitting our sustainability targets. I am proud that DSM Biomedical is aiming to exceed our customers' expectations by bringing sustainable solutions that alleviate their burdens and bring meaningful ESG benefits to their value chains."
Through their initial partner engagements at AAOS 2023, DSM Biomedical will remain determined in playing their part to reduce the industry's dependency on fossil resources. Their commitment to transitioning their trusted Dyneema Purity® UHMWPE fiber portfolio to wholly renewable feedstock, without disrupting the supply chain, is just one of many sustainability initiatives in the company's pipeline that will be announced in the coming years.
To learn more about this initiative and more, please visit DSM Biomedical's biomaterials experts in Las Vegas, Nevada at The Venetian Convention and Expo Center. Their team will be waiting to greet you in Booth 3032 from March 8, 2023 to March 10, 2023.
About DSM Biomedical
DSM Biomedical is a part of Royal DSM and the world's unrivaled biomaterials expert and committed partner in driving sustainable innovation in healthcare, the company has been at the forefront of biomaterial science and process innovation, and the leading resource for global medical device and pharmaceutical companies for more than 30 years. As a strategic partner with an approach driven not only by market dynamics but by the unique needs of every customer, DSM Biomedical brings an unparalleled breadth of product portfolios, proprietary manufacturing and processing capabilities, world-class IP, and extensive regulatory experience and expertise. Furthermore, DSM Biomedical's products and services are recognized for their unmatched quality, consistency, and performance in multiple markets across the globe, supporting their company-wide vision of solving the world's healthcare needs through sustainable science. To learn more, visit http://www.dsmbiomedical.com.
About Bio-Based Dyneema Purity® fibers
Bio-based Dyneema Purity® fiber delivers the same consistent quality and performance with a reduced environmental impact.
The fiber is certified according to ISCC, which guarantees good and sustainable practices while certifying that it originates from a transparent and traceable supply chain. It also guarantees that the number of bio-based materials sold is not more than the amount that is sourced. For more info regarding ISCC please visit http://www.iscc-system.org.
All bio-based raw materials are coming from sustainable certified sources. For further information on our partners, please visit http://www.upmbiofuels.com and http://www.sabic.com
¹Mass balance accounting is a well-known approach that has been designed to trace the flow of materials through a complex value chain. The mass balance approach provides a set of rules for how to allocate the bio-based and/or recycled content to different products to be able to claim and market the content as 'bio'-based or 'recycled'-based.
Source: Ellen MacArthur Foundation (Mass Balance White Paper).
About DSM
Royal DSM is a global, purpose-led company in Health, Nutrition & Bioscience, applying science to improve the health of people, animals and the planet. DSM's purpose is to create brighter lives for all. DSM's products and solutions address some of the world's biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. DSM and its associated companies employ approximately 23,000 people around the world and deliver annual net sales of about €10 billion. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at http://www.dsm.com.
Media Contact
Kathena Siegel, DSM Biomedical, 1 (215) 539-3255, [email protected]
SOURCE DSM Biomedical
Share this article